BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22129759)

  • 1. Bilateral polymicrobial osteomyelitis with Candida tropicalis and Candida krusei: a case report and an updated literature review.
    Kaldau NC; Brorson S; Jensen PE; Schultz C; Arpi M
    Int J Infect Dis; 2012 Jan; 16(1):e16-22. PubMed ID: 22129759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candida tropicalis in human disease.
    Chai LY; Denning DW; Warn P
    Crit Rev Microbiol; 2010 Nov; 36(4):282-98. PubMed ID: 20883082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two hundred and eleven cases of Candida osteomyelitis: 17 case reports and a review of the literature.
    Slenker AK; Keith SW; Horn DL
    Diagn Microbiol Infect Dis; 2012 May; 73(1):89-93. PubMed ID: 22578942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
    Krcmery V; Barnes AJ
    J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candida infections in non-neutropenic children after the neonatal period.
    Hacimustafaoglu M; Celebi S
    Expert Rev Anti Infect Ther; 2011 Oct; 9(10):923-40. PubMed ID: 21973304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neonatal Candida infections and the antifungal susceptibilities of the related Candida species].
    Altuncu E; Bilgen H; Cerikçioğlu N; Ilki A; Ulger N; Bakır M; Akman I; Ozek E
    Mikrobiyol Bul; 2010 Oct; 44(4):593-603. PubMed ID: 21063972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of yeasts isolated from patients in intensive care units to fluconazole and amphotericin B during a 3-year period.
    Kucukates E; Erturan Z; Susever S; Yegenoglu Y
    APMIS; 2005 Apr; 113(4):278-83. PubMed ID: 15865609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of aminocandin (IP960) compared with amphotericin B and fluconazole in a neutropenic murine model of disseminated infection caused by a fluconazole-resistant strain of Candida tropicalis.
    Warn PA; Sharp A; Morrissey G; Denning DW
    J Antimicrob Chemother; 2005 Sep; 56(3):590-3. PubMed ID: 16046462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
    Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
    Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vertebral osteomyelitis due to Candida species: case report and literature review.
    Miller DJ; Mejicano GC
    Clin Infect Dis; 2001 Aug; 33(4):523-30. PubMed ID: 11462190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a new formulation of amphotericin B in murine disseminated infections by Candida glabrata or Candida tropicalis.
    Mariné M; Espada R; Torrado J; Pastor FJ; Guarro J
    Int J Antimicrob Agents; 2009 Dec; 34(6):566-9. PubMed ID: 19733036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biofilm production and antifungal susceptibility patterns of Candida species].
    Yücesoy M; Karaman M
    Mikrobiyol Bul; 2004; 38(1-2):91-8. PubMed ID: 15293907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002.
    Yang YL; Li SY; Cheng HH; Lo HJ;
    Diagn Microbiol Infect Dis; 2005 Mar; 51(3):179-83. PubMed ID: 15766603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of Candida osteoarticular infections with limited duration of antifungal therapy and orthopedic surgical intervention.
    Miller AO; Gamaletsou MN; Henry MW; Al-Hafez L; Hussain K; Sipsas NV; Kontoyiannis DP; Roilides E; Brause BD; Walsh TJ
    Infect Dis (Lond); 2015 Mar; 47(3):144-9. PubMed ID: 25539148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successfully treated Candida krusei infection of the lumbar spine with combined caspofungin/posaconazole therapy.
    Schilling A; Seibold M; Mansmann V; Gleissner B
    Med Mycol; 2008 Feb; 46(1):79-83. PubMed ID: 17852716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
    Antoniadou A; Torres HA; Lewis RE; Thornby J; Bodey GP; Tarrand JP; Han XY; Rolston KV; Safdar A; Raad II; Kontoyiannis DP
    Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The comparative efficacy of cilofungin, fluconazole and amphotericin B in disseminated Candida tropicalis infection in neutropenic mice.
    Fong IW; Bannatyne RM; Cheng PC
    Clin Invest Med; 1992 Oct; 15(5):434-9. PubMed ID: 1458716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candida endophthalmitis: focus on current and future antifungal treatment options.
    Khan FA; Slain D; Khakoo RA
    Pharmacotherapy; 2007 Dec; 27(12):1711-21. PubMed ID: 18041891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006.
    Yang YL; Wang AH; Wang CW; Cheng WT; Li SY; Lo HJ;
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):175-80. PubMed ID: 18304773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibility of oral Candida to seven antifungal agents.
    Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
    Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.